Picture of Orgenesis logo

ORGS — Orgenesis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Orgenesis Inc expected to post a loss of 23 cents a share - Earnings Preview

* Orgenesis Inc  ORGS.OQ   ORGS.O  is expected to show a rise in
quarterly revenue when it reports results on August 4
(estimated). 
* The Germantown, Maryland-based company is expected to report 
 a 88.7% increase in revenue to $3.3 million from $1.75 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Orgenesis Inc is for a
loss of 23 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Orgenesis Inc
is $9​, about 45.6% above​ its last closing price of $4.90. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.26       -0.26      0.01      Beat    103.8
                                                        ​
 Mar.          ​           -0.20      -0.39     Missed  -95​
 31​ 2020​                                              
 Dec. 31 2019              -0.27      -0.42     Missed  -55.6​
 Sep. 30 2019  -0.28       -0.28      -0.44     Missed  -57.1
 Jun. 30 2019  -0.08       -0.08      -0.36     Missed  -350
 This summary was machine generated August 2 at 13:32 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Orgenesis

See all news